Branded Legacy (OTC: BLEG), a diversified holdings company focused on health and wellness solutions, announced the execution of a non-binding Letter of Intent to acquire Bio-Legacy Evaluative Group, a pioneer in advanced intranasal drug delivery technologies. The proposed $1.5 million Preferred D stock transaction would transfer 100% of Bio-Legacy’s equity, assets, and IP, supporting Branded Legacy’s entry into high-growth markets for addiction treatments and vaccine accessibility. Bio-Legacy’s patented naloxone device addresses cost and dosing challenges in a market projected to exceed $1.16 billion by 2032. Following the closing, Bio-Legacy CEO Amin Janmohamed will assume the roles of CEO and Chairman of Branded Legacy, with manufacturing prototyping targeted for Q3 2025 and market readiness for the naloxone device by Q1 2027.
To view the full press release, visit https://ibn.fm/5kuAK
About Branded Legacy Inc.
Branded Legacy is a forward-thinking company specializing in the development and commercialization of biotech and wellness products. With a focus on strategic growth, innovation and quality, the company is dedicated to enhancing lives and creating sustainable value for its shareholders.
For more information, visit the company’s website at https://BrandedLegacy.com.
About InvestorWire
InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer
InvestorWire
Austin, Texas
www.InvestorWire.com
512.354.7000 Office
Editor@InvestorWire.com
InvestorWire is powered by IBN
